SEARCH

SEARCH BY CITATION

Literature Cited

  • 1
    Koch TG,Heerkens T,Thomsen PD,Betts DH. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 2007; 7: 26. [doi:10.1186/1472-6750-7-26].
  • 2
    Reed SA,Johnson SE. Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. J Cell Physiol 2008; 215: 329336.
  • 3
    Fortier LA,Travis AJ. Stem cells in veterinary medicine. Stem Cell Res Ther 2011; 2: 9. [doi:10.1186/scrt50].
  • 4
    Richardson LE,Dudhia J,Clegg PD,Smith R. Stem cells in veterinary medicine—Attempts at regenerating equine tendon after injury. Trends Biotechnol 2007; 25: 409416.
  • 5
    Pacini S,Spinabella S,Trombi L,Fazzi R,Galimberti S,Dini F,Carlucci F,Petrini M. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng 2007; 13: 29492955.
  • 6
    Tárnok A,Ulrich H,Bocsi J. Phenotypes of stem cells from diverse origin. Cytometry Part A 2010; 77A: 610.
  • 7
    Dominici M,Le Blanc K,Mueller I,Slaper-Cortenbach I,Marini FC,Krause DS,Deans R,Keating A,Prockop DJ,Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315317.
  • 8
    De Schauwer C,Meyer E,Van de Walle GR,Van Soom A. Markers of stemness in equine mesenchymal stem cells: A plea for uniformity. Theriogenology 2011; 75: 14311443.
  • 9
    Hoynowski SM,Fry MM,Gardner BM,Leming MT,Tucker JR,Black L,Sand T,Mitchell KE. Characterization and differentiation of equine umbilical cord-derived matrix cells. Biochem Biophys Res Commun 2007; 362: 347353.
  • 10
    Guest DJ,Ousey JC,Smith MRW. Defining the expression of marker genes in equine mesenchymal stromal cells. Stem Cells Cloning: Adv Appl 2008; 1: 19.
  • 11
    Martinello T,Bronzini I,Maccatrozzo L,Iacopetti I,Sampaolesi M,Mascarello F,Patruno M. Cryopreservation does not affect the stem characteristics of multipotent cells isolated from equine peripheral blood. Tissue Eng Part C Methods 2010; 16, 771781.
  • 12
    Radcliffe CH,Flaminio MJBF,Fortier LA. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations. Stem Cells Dev 2010; 19: 269281.
  • 13
    Braun J,Hack A,Weis-Klemm M,Conrad S,Treml S,Kohler K,Walliser U,Skutella T,Aicher WK. Evaluation of the osteogenic and chondrogenic differentiation capacities of equine adipose tissue-derived mesenchymal stem cells. Am J Vet Res 2010; 71: 12281236.
  • 14
    Xie W,Wang X,Du W,Liu W,Qin X,Huang S. Detection of molecular targets on the surface of CD34+CD38 bone marrow cells in myelodysplastic syndromes. Cytometry Part A 2010; 77A: 840848.
  • 15
    Hughes OR,Stewart R,Dimmick I,Jones EA. A critical appraisal of factors affecting the accuracy of results obtained when using flow cytometry in stem cell investigations: Where do you put your gates? Cytometry Part A 2009; 75A: 803810.
  • 16
    MacEachern KE. Methods for the isolation, culture and characterization of equine pulmonary artery endothelial cells. Res Vet Sci 1997; 62: 147152.
  • 17
    Van de Walle GR,Peters ST,Van der Ven BC,O'Callaghan DJ,Osterrieder N. Equine herpesvirus 1 entry via endocytosis is facilitated by alpha V integrins and an RSD motif in glycoprotein D. J Virol 2008; 82: 1185911868.
  • 18
    De Schauwer C,Meyer E,Cornillie P,De Vliegher S,van de Walle GR,Hoogewijs M,Declercq H,Govaere J,Demeyere K,Cornelissen M,Van Soom A. Optimization of the isolation, culture and characterization of equine umbilical cord blood mesenchymal stromal cells. Tissue Eng Part C Methods 2011; 17: 10611070.
  • 19
    Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001; Appendix 3, Appendix 3B.
  • 20
    Ibrahim S,Saunders K,Kydd JH,Lunn DP,Steinbach F. Screening of anti-human leukocyte monoclonal antibodies for reactivity with equine leukocytes. Vet Immunol Immunopathol 2007; 119: 6380.
  • 21
    Martins AA,Paiva A,Morgado JM,Gomes A,Pais ML. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transplant Proc 2009; 41: 943946.
  • 22
    Brandtzaeg P,Jones DB,Flavell DJ,Fagerhol MK. Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen. J Clin Pathol 1988; 41: 963970.
  • 23
    Maurice S,Srouji S,Livne E. Isolation of progenitor cells from cord blood using adhesion matrices. Cytotechnology 2006; 52: 125137.
  • 24
    Jenhani F,Durand V,Ben Azouna N,Thallet S,Othmen B,Bejaoui M,Domenech J. Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells. Transplant Proc 2011; 43: 639643.
  • 25
    Vieira NM,Brandalise V,Zucconi E,Secco M,Strauss BE,Zatz M. Isolation, characterization, and differentiation potential of canine adipose-derived stem cells. Cell Transplant 2010; 19: 279289.
  • 26
    Bryniarski K,Maresz K,Szczepanik M,Ptak M,Ptak W. Modulation of macrophage activity by proteolytic enzymes. Differential regulation of IL-6 and reactive oxygen intermediates (ROIs) synthesis as a possible homeostatic mechanisms in the control of inflammation. Inflammation 2003; 27: 333340.
  • 27
    Mateusen B,Van Soom A,Maes DGD,Favoreel H,Nauwynck HJ. Receptor-determined susceptibility of preimplantation embryos to pseudorabies virus and porcine reproductive and respiratory syndrome virus. Biol Reprod 2007; 76: 415423.
  • 28
    Hackett CH,Flaminio MJBF,Fortier LA. Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow. Stem Cells Dev 2011; 20: 721735.
  • 29
    Turnovcova K,Ruzickova K,Vanecek V,Sykova E,Jendelova P. Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy 2009; 11: 874885.